Patent · US Active

Antibodies immunoreactive with heregulin-coupled HER3

US9321839B2 · kind B2 · utility

0Cited by

4References

6Claims

0Family size

Assignee

Trellis Bioscience, Inc. · US

Inventors

Bruce Keyt · Pacifica, US
Lawrence M. Kauvar · San Francisco, US
Ellen J. Collarini · Oakland, US
Orit Foord · Foster City, US
Gizette Sperinde · El Granada, US
Marjan Fatholahi · Mountain View, US
Hung Q. Nguyen · Thousand Oaks, US

Key dates

Filing date	Sep 2, 2014
Grant date	Apr 26, 2016
Priority date	—
Expiry date	Sep 2, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Recombinant materials and methods for producing antibodies that specifically bind heregulin-coupled HER3, at a site distinct from the heregulin binding site, are described. These antibodies are particularly useful in treating cancer that expresses HER3.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.